Alkylating agents in membranous nephropathy: efficacy proven beyond doubt
- 3 February 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 25 (6), 1760-1766
- https://doi.org/10.1093/ndt/gfq017
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Advisory BoardsAmerican Journal of Kidney Diseases, 2009
- Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2008
- A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous NephropathyJournal of the American Society of Nephrology, 2007
- A Randomized Pilot Trial Comparing Methylprednisolone Plus a Cytotoxic Agent Versus Synthetic Adrenocorticotropic Hormone in Idiopathic Membranous NephropathyAmerican Journal of Kidney Diseases, 2006
- Journal of the American Society of Nephrology, 2005
- Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamideAnnals Of The Rheumatic Diseases, 2004
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rateNephrology Dialysis Transplantation, 2004
- Clinical Subtypes of Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1998
- Bladder and Kidney Cancer Following Cyclophosphamide Therapy for Non-Hodgkin's LymphomaJNCI Journal of the National Cancer Institute, 1995